$13.09
0.69% day before yesterday
Nasdaq, Nov 01, 09:00 pm CET
ISIN
US1717571079
Symbol
CDTX
Sector
Industry

Cidara Therapeutics, Inc. Target price 2024 - Analyst rating & recommendation

Cidara Therapeutics, Inc. Classifications & Recommendation:

Buy
100%

Cidara Therapeutics, Inc. Price Target

Target Price $24.50
Price $13.09
Potential
Number of Estimates 2
2 Analysts have issued a price target Cidara Therapeutics, Inc. 2025 . The average Cidara Therapeutics, Inc. target price is $24.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 3 Analysts recommend Cidara Therapeutics, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cidara Therapeutics, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Cidara Therapeutics, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 63.91 10.00
0.59% 84.35%
Net Margin -37.54% -1,187.74%
1,128.19% 3,063.84%

2 Analysts have issued a sales forecast Cidara Therapeutics, Inc. 2024 . The average Cidara Therapeutics, Inc. sales estimate is

$10.0m
Unlock
. This is
74.40% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$11.2m 71.33%
Unlock
, the lowest is
$8.8m 77.48%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $63.9m 0.59%
2024
$10.0m 84.35%
Unlock
2025
$0.0 100.00%
Unlock

3 Cidara Therapeutics, Inc. Analysts have issued a net profit forecast 2024. The average Cidara Therapeutics, Inc. net profit estimate is

$-119m
Unlock
. This is
4.29% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-107m 5.69%
Unlock
, the lowest is
$-140m 23.07%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-24.0m 1,120.93%
2024
$-119m 395.03%
Unlock
2025
$-45.7m 61.56%
Unlock
2026
$-43.3m 5.06%
Unlock
2027
$-39.6m 8.74%
Unlock
2028
$-23.0m 41.77%
Unlock

Net Margin

2023 -37.54% 1,128.19%
2024
-1,187.74% 3,063.84%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -5.25 -25.99
1,120.93% 395.05%
P/E negative
EV/Sales negative

3 Analysts have issued a Cidara Therapeutics, Inc. forecast for earnings per share. The average Cidara Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-25.99
Unlock
. This is
4.29% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-23.50 5.70%
Unlock
, the lowest is
$-30.67 23.07%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-5.25 1,120.93%
2024
$-25.99 395.05%
Unlock
2025
$-9.99 61.56%
Unlock
2026
$-9.48 5.11%
Unlock
2027
$-8.65 8.76%
Unlock
2028
$-5.04 41.73%
Unlock

P/E ratio

Current -0.53 91.64%
2024
-0.50 5.66%
Unlock
2025
-1.31 162.00%
Unlock
2026
-1.38 5.34%
Unlock
2027
-1.51 9.42%
Unlock
2028
-2.60 72.19%
Unlock

Based on analysts' sales estimates for 2024, the Cidara Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

-6.79
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -1.74 700.00%
2024
-6.79 290.46%
Unlock

P/S ratio

Current 2.36 184.73%
2024
9.21 290.70%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today